IA2030 Scorecard
—Global
- 1.2 Health workforce1.6 Vaccine safety2.1 Political and financial commitment2.2 Demand for immunization3.2 High & equitable coverage4.1 Life-course vaccination5.1 Outbreak detection and response6.1 Healthy global markets for vaccines6.2 Financial resources for imm. programmes6.3 Imm. expenditure from domestic resources7.1 Capacity for innovation
Type to select a Country
High and equitable coverage
Summary Table
| Antigen | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| DTPCV3 | 74% | 72% | 68% | 69% |
| MCV1 | 72% | 71% | 67% | 66% |
| MCV2 | 64% | 62% | 58% | 57% |
Step 1) Calculate missing values where applicable. Recalculate the number of doses or the target number if possible.
Step 2) Exclude districts if any of the three relevant values (number of doses, target number, and coverage) are missing.
Step 3) Identify the 20% of districts with lowest coverage. For each country, year, and vaccine, order the districts by – 1) ascending coverage and 2) ascending target number. In case multiple districts with the same coverage are spread across multiple quintiles, this will allow districts with smaller population to be classified into lower quintiles. Districts ranking between 1 and (0.2 * total number of districts in the country) are defined as 20% of districts with lowest coverage.
Step 4) Calculate the indicator value.
Country level: Calculate the weighted coverage across the 20% of districts with lowest coverage for each country, year, and vaccine.
- Numerator: Total number of doses in the 20% lowest districts
- Denominator: Total target number in the 20% lowest districts
Regional and global level: Calculate the non-weighted average using the national aggregation
Accessed: undefined
